News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
Thong has nearly 30 years of experience in leadership and commercial roles and is a guest lecturer on R&D alliances at institutions including the University of Cambridge and University College London.
Thong commented that de-risking clinical failure is one of the biggest challenges in drug development.
“I believe that by creating a global marketplace that gives access to a broader range and better characterized preclinical models, and which works for all stakeholders, we can have the greatest positive impact,” he told us.
“I am incredibly excited to use my experience to establish Repositive’s Cancer Models community and marketplace, and to help grow the company globally.”